Korean stem cell treatment technology acquired approval in Japan for the first time

Published: 2015-11-12 09:45:34

Updated: 2015-11-12 09:45:34

R-Japan Co., Ltd., a Japanese affiliated company of Nature Cell, announced on the 11^th that Nishihara Medical Clinic acquired approval of stem cell treatment for critical limb ischemia diseases, which includes Burger’s disease, from the Japanese Ministry of Health, Labour, and Welfare, led by Biostar Stem Cell Research and Development.

The event is meaningful as Biostar Stem Cell Research and ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.